{"credit":[{"email":"yshen3@bu.edu","name":"Ying Shen","typeEntity":"Person","typeRoles":["Primary contact"]}],"documentation":[{"url":"http://bioconductor.org/packages/release/bioc/html/ASSIGN.html"}],"download":[{"type":"Source code","url":"http://bioconductor/packages/release/bioc/src/contrib/ASSIGN_1.10.0.tar.gz"}],"function":[{"input":[{"data":{"term":"Gene expression matrix","uri":"http://edamontology.org/data_3112"},"format":[{"term":"Gene expression report format","uri":"http://edamontology.org/format_2058"},{"term":"Biological pathway or network format","uri":"http://edamontology.org/format_2013"}]},{"data":{"term":"Pathway or network","uri":"http://edamontology.org/data_2600"},"format":[{"term":"Gene expression report format","uri":"http://edamontology.org/format_2058"},{"term":"Biological pathway or network format","uri":"http://edamontology.org/format_2013"}]}],"operation":[{"term":"Gene to pathway mapping","uri":"http://edamontology.org/operation_0533"}],"output":[{"data":{"term":"Score","uri":"http://edamontology.org/data_1772"},"format":[{"term":"Textual format","uri":"http://edamontology.org/format_2330"}]},{"data":{"term":"Pathway or network","uri":"http://edamontology.org/data_2600"},"format":[{"term":"Textual format","uri":"http://edamontology.org/format_2330"}]}]}],"labels":{"collectionID":["BioConductor"],"language":["R"],"license":"MIT","operatingSystem":["Linux","Windows","Mac"],"toolType":["Command-line tool","Library"],"topic":[{"term":"Molecular interactions, pathways and networks","uri":"http://edamontology.org/topic_0602"},{"term":"Statistics and probability","uri":"http://edamontology.org/topic_2269"}]},"publication":[{"abstract":"Â© The Author 2015. Published by Oxford University Press. All rights reserved. Motivation: Although gene-expression signature-based biomarkers are often developed for clinical diagnosis, many promising signatures fail to replicate during validation. One major challenge is that biological samples used to generate and validate the signature are often from heterogeneous biological contexts-controlled or in vitro samples may be used to generate the signature, but patient samples may be used for validation. In addition, systematic technical biases from multiple genome-profiling platforms often mask true biological variation. Addressing such challenges will enable us to better elucidate disease mechanisms and provide improved guidance for personalized therapeutics. Results: Here, we present a pathway profiling toolkit, Adaptive Signature Selection and InteGratioN (ASSIGN), which enables robust and context-specific pathway analyses by efficiently capturing pathway activity in heterogeneous sets of samples and across profiling technologies. The ASSIGN framework is based on a flexible Bayesian factor analysis approach that allows for simultaneous profiling of multiple correlated pathways and for the adaptation of pathway signatures into specific disease. We demonstrate the robustness and versatility of ASSIGN in estimating pathway activity in simulated data, cell lines perturbed pathways and in primary tissues samples including The Cancer Genome Atlas breast carcinoma samples and liver samples exposed to genotoxic carcinogens. Availability and implementation: Software for our approach is available for download at: http:// www.bioconductor.org/packages/release/bioc/html/ASSIGN.html and https://github.com/wevan johnson/ASSIGN.","authors":["Shen Y.","Rahman M.","Piccolo S.R.","Gusenleitner D.","El-Chaar N.N.","Cheng L.","Monti S.","Bild A.H.","Johnson W...E."],"cit_count":13,"doi":"10.1093/bioinformatics/btv031","journal":"Bioinformatics","title":"ASSIGN: Context-specific genomic profiling of multiple heterogeneous biological pathways","type":"Primary","year":"2015-01-01"}],"summary":{"biotoolsCURIE":"biotools:assign","biotoolsID":"assign","description":"Tool to evaluate the pathway deregulation/activation status in patient samples. It employs a Bayesian factor analysis approach to adapt predetermined pathway signatures derived from knowledge-based literatures or from perturbation experiments to the cell-/tissue-specific pathway signatures. The deregulation/activation level of each context-specific pathway is quantified to a score, which represents the extent to which a patient sample encompasses the pathway deregulation/activation signature.","homepage":"http://bioconductor.org/packages/release/bioc/html/ASSIGN.html","name":"ASSIGN","version":["1.10.0"]}}